ETHZilla Corp Reports Director/Officer Changes & Compensatory Arrangements
Ticker: FRMM · Form: 8-K · Filed: Dec 1, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | Ethzilla CORP (FRMM) |
| Form Type | 8-K |
| Filed Date | Dec 1, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation, corporate-actions
TL;DR
ETHZilla Corp (formerly 180 Life Sciences) filed an 8-K on Dec 1, 2025, reporting board/exec changes and compensation updates.
AI Summary
On December 1, 2025, ETHZilla Corporation filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to compensatory arrangements. The filing also includes financial statements and exhibits. ETHZilla Corporation, formerly known as 180 Life Sciences Corp. and KBL Merger Corp. IV, is incorporated in Delaware and operates in the Finance Services sector.
Why It Matters
This filing indicates potential shifts in company leadership and compensation structures, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with updates to compensation, can signal internal shifts that may affect future performance and strategy.
Key Players & Entities
- ETHZilla Corporation (company) — Registrant
- 180 Life Sciences Corp. (company) — Former Company Name
- KBL Merger Corp. IV (company) — Former Company Name
- December 1, 2025 (date) — Date of Report
FAQ
What specific changes were made to ETHZilla Corporation's board of directors or certain officers?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of report, but the specific details of these changes are not provided in the provided text.
What kind of updates were made to the compensatory arrangements of certain officers?
The filing lists "Compensatory Arrangements of Certain Officers" as an item of report, but the specific details of these arrangements are not included in the provided text.
When was the name change from 180 Life Sciences Corp. to ETHZilla Corporation?
The date of name change from 180 Life Sciences Corp. was November 6, 2020.
What is ETHZilla Corporation's Standard Industrial Classification (SIC) code?
ETHZilla Corporation's SIC code is 6199, categorized under Finance Services.
What is the business address of ETHZilla Corporation?
The business address of ETHZilla Corporation is 2875 South Ocean Street, Suite 200, Palm Beach, FL 33480.
Filing Stats: 725 words · 3 min read · ~2 pages · Grade level 13.7 · Accepted 2025-12-01 16:32:18
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ETHZ The NASDAQ Stock Mar
Filing Documents
- ea0267909-8k_ethzilla.htm (8-K) — 27KB
- ea026790901ex10-1_ethzilla.htm (EX-10.1) — 17KB
- 0001213900-25-116726.txt ( ) — 211KB
- ethz-20251201.xsd (EX-101.SCH) — 3KB
- ethz-20251201_lab.xml (EX-101.LAB) — 33KB
- ethz-20251201_pre.xml (EX-101.PRE) — 22KB
- ea0267909-8k_ethzilla_htm.xml (XML) — 4KB
02 Departure of Directors or Certain Officers; Election of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed in the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2025, ETHZilla Corporation (the "Company") granted shares of restricted common stock of the Company, par value $0.0001 per share ("Common Stock") to Mr. McAndrew Rudisill, the Company's Chairman and Chief Executive Officer ("CEO"), and to each director of the Company (the "Directors") on November 12, 2025, pursuant to the terms of the 2025 Omnibus Incentive Plan, approved by the Company's stockholders at a Special Meeting held on October 7, 2025 (the "Awards"). Following the disclosure of the Awards, the Company received feedback from stockholders expressing concerns regarding the structure of certain of the Awards. The Board of Directors and the Compensation Committee carefully considered this shareholder feedback, together with other relevant factors, and determined to revisit certain equity compensation awards made on November 12, 2025 as specified below. On December 1, 2025, upon the recommendation of the Compensation Committee, the Board of Directors approved the rescission and cancellation, in their entirety and effective immediately, of the shares of restricted Common Stock previously granted to the CEO and each Director on November 12, 2025. In addition, on December 1, 2025, the CEO and each Director entered into a Restricted Stock Award Rescission Agreement (each a "Rescission Agreement") with the Company pursuant to which each of them acknowledged and agreed to the rescission and cancellation of the Awards. No consideration was paid in connection with these rescissions, and all such awards have been cancelled. The Company expects that the CEO and each Director will file an updated Form 4 pursuant to Section 16 of the Securities Exchange Act of 1934, as amended. The previous
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 1, 2025 ETHZilla Corporation By: /s/ McAndrew Rudisill Name: McAndrew Rudisill Title: Chief Executive Officer 2